Upgrade to SI Premium - Free Trial

Durect (DRRX) PT Lifted to $3 at Cantor Fitzgerald on Solid Q1 and Multiple Catalysts

May 1, 2015 7:23 AM
Cantor Fitzgerald analyst Irina Rivkind Koffler reiterated a Buy rating and bumped her price target on Durect Corp (NASDAQ: DRRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change FDA

Next Articles